Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T16459 | Target Info | |||
Target Name | CDK inhibitor 1C p57Kip2 (CDKN1C) | ||||
Synonyms | P57KIP2; P57(KIP2); KIP2; Cyclin-dependent kinase inhibitor p57; Cyclin-dependent kinase inhibitor 1C | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CDKN1C | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Cell cycle related proteins | [+] 2 Cell cycle related proteins | + | |||
Interacting Target Name | G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRAD1 oncogene; PRAD1; Cyclin D1; BCL-1 oncogene; BCL-1; BCL1; B-cell lymphoma 1 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
3 | Reconstituted Complex | [1] | |||
Interacting Target Name | Cyclin A2 (CCNA2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin-A2; Cyclin-A; Cyclin A; CCNA | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-Western | [4] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Target Name | S-phase kinase-associated protein 2 (SKP2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Skp2; P45skp2; FBXL1; F-box/LRR-repeat protein 1; F-box protein Skp2; Cyclin-A/CDK2-associated protein p45; Cyclin A/CDK2-associated protein p45; Cyclin A/CDK2-associated p45 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Biochemical Activity | [6] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity. Oncogene. 2000 Feb 24;19(9):1147-52. | ||||
REF 2 | Stabilization of MyoD by direct binding to p57(Kip2). J Biol Chem. 2000 Jun 23;275(25):18767-76. | ||||
REF 3 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 4 | The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain. J Biol Chem. 2003 Nov 7;278(45):44255-64. | ||||
REF 5 | SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology. 2009 Nov;137(5):1816-26.e1-10. | ||||
REF 6 | Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10231-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.